Joseph Donald
Insider CIK 1319460 · ACER See Remarks · KBIO Chief Legal Officer · ACHV Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACER Acer Therapeutics Inc. | D To issuer | 2023-11-17 | 2023-11-20 | 14,285 | — | $0 | 0 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2023-03-14 | 2023-03-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2022-05-31 | 2022-06-01 | 4,400 | — | $0 | 4,400 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2022-01-14 | 2022-01-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2021-05-11 | 2021-05-13 | 3,750 | — | $0 | 3,750 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2021-01-15 | 2021-01-20 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ACER Acer Therapeutics Inc. | P Buy | 2020-07-24 | 2020-07-28 | 14,285 | $3.50 | $50.0K | 14,285 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2020-05-12 | 2020-05-14 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2019-09-18 | 2019-09-23 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2019-05-14 | 2019-05-15 | 7,000 | — | $0 | 7,000 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2019-02-01 | 2019-02-05 | 27,000 | — | $0 | 27,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2018-09-20 | 2018-09-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ACER Acer Therapeutics Inc. | A Award deriv | 2018-04-20 | 2018-04-23 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2017-08-01 | 2017-08-03 | 16,400 | — | $0 | 16,400 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2017-08-01 | 2017-09-12 | 16,400 | — | $0 | 16,400 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2015-02-16 | 2015-02-18 | 300,000 | — | $0 | 300,000 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2014-01-19 | 2014-01-22 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KBIO KALOBIOS PHARMACEUTICALS I | A Award deriv | 2013-07-30 | 2013-08-01 | 125,000 | — | $0 | 125,000 | SEC↗ |